AP-1 activated by docetaxel appears to target Gadd153/CHOP in gastric cancer cells [119] and that activated by VBL appears to target Fas-L, TNF-α, and Bak in epidermoid carcinoma cells [111]. The gene discussed is DDIT3; the disease is gastric cancer.